Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
1.650
+0.170 (11.49%)
At close: Jun 26, 2026, 4:00 PM EDT
1.520
-0.130 (-7.88%)
After-hours: Jun 26, 2026, 7:46 PM EDT
Dogwood Therapeutics Employees
Dogwood Therapeutics had 8 employees as of December 31, 2025. The number of employees decreased by 4 or -33.33% compared to the previous year.
Employees
8
Change (1Y)
-4
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$3,539,879
Market Cap
55.49M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Xilio Therapeutics | 76 |
| aTyr Pharma | 60 |
| Boundless Bio | 28 |
| PDS Biotechnology | 21 |
| Filana Therapeutics | 20 |
| Instil Bio | 17 |
| Lantern Pharma | 16 |
| Context Therapeutics | 15 |
DWTX News
- 5 weeks ago - Dogwood begins Phase 2b extension study for Halneuron - TheFly
- 5 weeks ago - Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study - GlobeNewsWire
- 6 weeks ago - Dogwood Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Dogwood Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Dogwood Therapeutics Announces First Quarter 2026 Financial Results - GlobeNewsWire
- 6 weeks ago - Dogwood Therapeutics Slides: Corporate presentation - Filings
- 7 weeks ago - Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - GlobeNewsWire
- 2 months ago - Dogwood Therapeutics Proxy statement: Proxy filing - Filings